Experts are excitedly examining retatrutide, a promising treatment from Eli Lilly, as a potential breakthrough in weight management. Unlike many existing approaches, retatrutide is a dual -action compound targeting both GLP-1 and GIP, chemicals that impact satiety and glucose regulation . Early … Read More